Literature DB >> 14600577

The interface of perinatal HIV prevention, antiretroviral drug resistance, and antiretroviral treatment: what do we really know?

Mary Glenn Fowler, Lynne Mofenson, Michelle McConnell.   

Abstract

Mesh：

Substances：

Year:  2003        PMID： 14600577     DOI： 10.1097/00126334-200311010-00009

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN： 1525-4135            Impact factor:   3.731


× No keyword cloud information.
  4 in total

1.  Outcome of different nevirapine administration strategies in preventing mother-to-child transmission (PMTCT) programs in Tanzania and Uganda.

Authors:  Heiko Karcher; Andrea Kunz; Gabriele Poggensee; Paulina Mbezi; Kizito Mugenyi; Gundel Harms
Journal:  MedGenMed       Date:  2006-04-12

2.  Early clinical and immune response to NNRTI-based antiretroviral therapy among women with prior exposure to single-dose nevirapine.

Authors:  Benjamin H Chi; Moses Sinkala; Elizabeth M Stringer; Ronald A Cantrell; Velepi Mtonga; Marc Bulterys; Isaac Zulu; Chipepo Kankasa; Catherine Wilfert; Paul J Weidle; Sten H Vermund; Jeffrey S A Stringer
Journal:  AIDS       Date:  2007-05-11       Impact factor: 4.177

3.  Outcome of Different Nevirapine Administration Strategies in Preventin g Mother-to-Child Transmission (PMTCT) Programs in Tanzania and Uganda.

Authors:  Heiko Karcher; Andrea Kunz; Gabriele Poggensee; Paulina Mbezi; Kizito Mugenyi; Gundel Harms
Journal:  J Int AIDS Soc       Date:  2006-04-12       Impact factor: 5.396

4.  Response to antiretroviral therapy (ART): comparing women with previous use of zidovudine monotherapy (ZDVm) in pregnancy with ART naïve women.

Authors:  Susie Huntington; Claire Thorne; Jane Anderson; Marie-Louise Newell; Graham P Taylor; Deenan Pillay; Teresa Hill; Pat Tookey; Caroline Sabin
Journal:  BMC Infect Dis       Date:  2014-03-04       Impact factor: 3.090
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.